MIDEXtrackers S&P MidCap 400 Scored & Screened ETF
Seeks investment results that correspond generally to the performance of the S&P MidCap 400 Scored & Screened Index.
By Xtrackers · Launched 2021
Annual Cost
0.15%
#612 of 5,861 · low cost
Fund Size
$3M
#5,344 of 5,861 · small
Return (1Y)Goal
+22.2%
Track Record
5 years
#2,258 of 5,861 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$12,555+25.5%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaCap
Mid
Strategy
Index tracking
Focus
ESG
Index tracked
S&P MidCap 400 Scored & Screened Index
What it actually holds
By weightConcentration
Top 10 holdings = 11.9% of fund✓ well diversified
Lumentum Holdings Inc.
2.2%
Coherent Corp
1.8%
Royal Gold, Inc.
1.1%
FLEX LTD
1.0%
United Therapeutics Corporation
1.0%
US Foods Holding Corp
1.0%
Tenet Healthcare Corporation
1.0%
Illumina Inc
0.9%
Pure Storage Inc
0.9%
Entegris Inc
0.9%
Asset allocation
Stocks
98.7%
Cash
1.3%
By sector
Industrials
23.4%
Technology
16.5%
Financial Services
15.8%
Consumer Cyclical
11.2%
Healthcare
9.3%
Real Estate
8.6%
Energy
5.2%
Basic Materials
4.1%
Other
5.9%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
15.9%Moderate
Year-on-year price swings
Max drawdown
-24.6%Moderate
Worst peak-to-trough loss
Sharpe (3Y)
0.57Decent risk-adjusted returns
Sortino (3Y)
0.84Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks investment results that correspond generally to the performance of the S&P MidCap 400 Scored & Screened Index.
- Strategy
- Employs a passive indexing approach to track the S&P MidCap 400 Scored & Screened Index, which is market capitalization weighted and focuses on companies meeting ESG criteria. The fund uses full replication indexing, investing directly in component securities in similar weightings as the index.
- Inception date
- February 23, 2021
- Fund family
- Xtrackers
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at MIDE. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-04